|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002395,
umls-concept:C0002716,
umls-concept:C0003595,
umls-concept:C0007806,
umls-concept:C0017431,
umls-concept:C0080103,
umls-concept:C0205251,
umls-concept:C0332140,
umls-concept:C0441889,
umls-concept:C1720655,
umls-concept:C1947974,
umls-concept:C2700455
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1998-8-6
|
|
pubmed:abstractText |
To evaluate cerebrospinal fluid (CSF) levels of amyloid beta protein ending at amino acid 42 (Abeta42) and tau as markers for Alzheimer disease (AD) and to determine whether clinical variables influence these levels.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0003-9942
|
|
pubmed:author |
pubmed-author:BasheradRR,
pubmed-author:BirdH RHR,
pubmed-author:ChangLL,
pubmed-author:ClarkC MCM,
pubmed-author:GalaskoDD,
pubmed-author:GreenRR,
pubmed-author:KayeJJ,
pubmed-author:KertilesLL,
pubmed-author:KholodenkoDD,
pubmed-author:KnopmanDD,
pubmed-author:LieberburgII,
pubmed-author:MillerBB,
pubmed-author:MottesMM,
pubmed-author:SchenkDD,
pubmed-author:SeubertPP,
pubmed-author:ThomasRR
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
937-45
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9678311-Adult,
pubmed-meshheading:9678311-Aged,
pubmed-meshheading:9678311-Aged, 80 and over,
pubmed-meshheading:9678311-Alzheimer Disease,
pubmed-meshheading:9678311-Amyloid beta-Peptides,
pubmed-meshheading:9678311-Apolipoproteins E,
pubmed-meshheading:9678311-Biological Markers,
pubmed-meshheading:9678311-Dementia,
pubmed-meshheading:9678311-Diagnosis, Differential,
pubmed-meshheading:9678311-Female,
pubmed-meshheading:9678311-Genotype,
pubmed-meshheading:9678311-Humans,
pubmed-meshheading:9678311-Male,
pubmed-meshheading:9678311-Middle Aged,
pubmed-meshheading:9678311-Neuropeptides,
pubmed-meshheading:9678311-Peptide Fragments,
pubmed-meshheading:9678311-tau Proteins
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
|
|
pubmed:affiliation |
Department of Neurosciences, University of California, San Diego, San Diego Veterans Affairs Medical Center, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
